NCT05236348

Brief Summary

This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
225

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

January 11, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 11, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

August 19, 2024

Status Verified

August 1, 2024

Enrollment Period

3.2 years

First QC Date

December 28, 2021

Last Update Submit

August 16, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Blood pressure mean value of differences

    The mean value of the differences between Aktiia.product-us and double auscultation blood pressure measurements.

    1 week

  • Blood pressure standard deviation of differences

    The standard deviation of the differences between Aktiia.product-us and double auscultation blood pressure measurements.

    1 week

Secondary Outcomes (1)

  • Heart rate root-mean-square error

    1 week

Study Arms (2)

Patients 21-60yo with Aktiia.product-us

EXPERIMENTAL

All study participants will wear the Aktiia.product-us during 9 visits that will be held over the span of seven days.

Device: Aktiia.product-us

Patients 60-85yo with Aktiia.product-us

EXPERIMENTAL

All study participants will wear the Aktiia.product-us during 9 visits that will be held over the span of seven days.

Device: Aktiia.product-us

Interventions

The study will collect data from subjects by means of the device under test and collect data from subjects by means of double-auscultation, pulse oximetry and volume-clamp BP reading while subjects wear the devices at different body positions and induce BP changes, during eight visits that will be held over the span of seven days, and generate performance reports.

Also known as: Aktiia bracelet, Aktiia product, Aktiia.product
Patients 21-60yo with Aktiia.product-usPatients 60-85yo with Aktiia.product-us

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subjects (aged between 21 and 85 years old)
  • Subjects can read and speak French
  • Subjects can perform simple physical exercises
  • Subjects agreeing to attend the totality of 9 visits
  • Subjects that have signed the informed consent form

You may not qualify if:

  • Clinical staff collaborating with study PI
  • Subjects with tachycardia (heart rate at rest \> 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with diabetes
  • Subjects with renal dysfunctions
  • Subjects with hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with trembling and shivering
  • Subjects with interarm systolic difference \> 15 mmHg
  • Subjects with interarm diastolic difference \> 10 mmHg
  • Subjects with arm paralysis
  • Women in known pregnancy (for ARM 1 only)
  • Subjects with an arteriovenous fistula
  • Subjects with arm amputations
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Lausanne Hospitals

Lausanne, 1011, Switzerland

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Gregoire Wuerzner, MD

    Service of Nephrology and Hypertension CHUV

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Josep Sola, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All study participants will wear the Aktiia.bracelet-us during 9 visits that will be held over the span of seven days. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises during these visits.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2021

First Posted

February 11, 2022

Study Start

January 11, 2022

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

August 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations